ClinicalTrials.Veeva

Menu

Controlled Acute Hypoxia Study Comparing Pulse Oximetry to Arterial Blood Samples During Motion

Medtronic logo

Medtronic

Status and phase

Completed
Phase 3

Conditions

Healthy
Hypoxia

Treatments

Device: Motion
Device: Arterial line

Study type

Interventional

Funder types

Industry

Identifiers

NCT02247765
COVMOPR0445

Details and patient eligibility

About

To validate the proposed claims for pulse rate and saturation accuracy in a diverse subject population during motion over a specified saturation range.

Full description

Use an investigational oximetry system to evaluate the triggering of the "sensor off" status with marketed, off-the-shelf sensors.

Enrollment

18 patients

Sex

All

Ages

18 to 50 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Male or female of any race
  • 18-50 years old, inclusive
  • Females: negative urine pregnancy test on the day of study participation (prior to exposure to hypoxia)
  • Completed within the last year: physical exam by a licensed physician, physician assistant (PA), or advanced practice nurse; including a 12 lead ECG, a medical history, and blood test (complete blood count and sickle cell trait/disease screening)
  • Meets specific demographic requirements for the monitoring device under study
  • Willing and able to provide written informed consent
  • Able to participate for the duration of the evaluation

Exclusion criteria

  • A room-air baseline % modulation < 1.5% on all four fingers on the test hand
  • Under 18 years or over 50 years of age
  • Pregnant and/or lactating women
  • Hypertension: on three consecutive readings, systolic pressure greater than 145 mm Hg or diastolic pressure greater than 90 mm Hg
  • Ventricular premature complexes (VPC's) that are symptomatic or occur at a rate of more than four per minute
  • History of seizures (except childhood febrile seizures) or epilepsy
  • History of unexplained syncope
  • Daily or more frequent use of anxiolytic drugs (benzodiazepines) for treatment of anxiety disorder
  • Recent history of frequent migraine headaches: average of two or more per month over the last year
  • Compromised circulation, injury, or physical malformation of fingers, toes, hands, ears or forehead/skull or other sensor sites which would limit the ability to test sites needed for the study. (Note: Certain malformations may still allow subjects to participate if the condition is noted and would not affect the particular sites utilized.)
  • History of acute altitude sickness at or below moderate elevation (up to 5,000-10,000 feet) defined as three or more of the following symptoms: moderate to severe headache, general malaise, dizziness/lightheadedness, nausea/vomiting, fatigue/weakness, shortness of breath, nosebleed, persistent rapid pulse, or peripheral edema
  • History of significant respiratory disease such as severe asthma or emphysema or sleep apnea
  • Sickle cell disease or trait
  • Clinically significant abnormal finding on medical history, physical examination, clinical laboratory test or ECG. Clinical significance will be assessed by the principal investigator or study physician as designated.
  • History of stroke, transient ischemic attack or carotid artery disease
  • History of myocardial ischemia, angina, myocardial infarction, congestive heart failure or cardiomyopathy
  • History of chronic renal impairment
  • Severe contact allergies to standard adhesives, latex or other materials found in pulse oximetry sensors, ECG electrodes, respiration monitor electrodes or other medical sensors
  • Unwillingness or inability to remove colored nail polish or artificial nails from test digit(s)
  • Unwillingness or inability to give informed consent
  • Prior or known allergies to: lidocaine (or similar pharmacological agents, e.g., Novocain) or heparin
  • Recent arterial cannulation (i.e., less than 30 days prior to study date)
  • Six or more arterial cannulations of each (right & left) radial artery
  • History of clinically significant complications from previous arterial cannulation
  • Current use of blood thinners: prescription or daily aspirin use
  • History of bleeding disorders or personal history of prolonged bleeding from injury.

Trial design

Primary purpose

Basic Science

Allocation

Non-Randomized

Interventional model

Single Group Assignment

Masking

None (Open label)

18 participants in 2 patient groups

Arterial Line
Experimental group
Description:
CO-Oximetry value obtained as a comparator. Obtained during motion conditions.
Treatment:
Device: Arterial line
Motion
Experimental group
Description:
The subject has to perform motions during the procedure. This is to verify that device is able to read through motion.
Treatment:
Device: Motion

Trial contacts and locations

2

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems